Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 4
Submit an article Journal homepage
198
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol

Anna Maria TestiDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy; Correspondence[email protected]
,
Maria Luisa MoletiDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy;
,
Martina CanichellaDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy;
,
Sara MohamedDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy;
,
Daniela DiverioDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy;
,
Maria Stefania de ProprisDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy;
,
Franco LocatelliDepartment of Pediatric Hematology/Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Pediatrico Bambino Gesù, Rome, Italy and University of Pavia, Pavia, Italy;
,
Francesco Lo CocoDepartment of Biomedicine and Prevention, ‘Tor Vergata’ University, Rome, Italy
&
Robin FoàDepartment of Cellular Biotechnologies and Hematology, ‘Sapienza’, University, Rome, Italy;
show all
Pages 999-1001 | Received 04 Jun 2016, Accepted 03 Aug 2016, Published online: 23 Sep 2016

References

  • Ferrara F, Selleri C, Mele G, et al. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. Ann Hematol. 2004;83:484–486.
  • Ebinger M, Schwarze CP, Feuchtinger T, et al. Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boy. Pediatr Hematol Oncol. 2011;28:334–337.
  • Latagliata R, Carmosino I, Breccia M, et al. Late relapses in acute promyelocytic leukaemia. Acta Haematol. 2007;117:106–108.
  • Douer D, Zickl LN, Schiffer CA, et al. All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129. Leuk Res. 2013;37:795–801.
  • Au WY, Chan GFC, Chim CS, et al. External auditory canal tumor: a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide. Unusual sites of involvement by hematologic malignancies. J Clin Oncol. 2001;19:3993–3995.
  • Breccia M, Petti MC, Testi AM, et al. Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? Leukemia. 2002;16:1127–1130.
  • Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106:447–453.
  • Estey E, Garcia-Manero G, Ferrajoli A, et al. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood. 2006;107:3469–3473.
  • Ganzel C, Douer D. Extramedullary disease in APL: a real phenomenon to contend with or not? Best Pract Res Clin Haematol. 2014;27:63–68.
  • Au WY, Tam S, Kwong YL. Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment. Leuk Res. 2008;32:357–358.
  • Lengfelder E, Lo Coco F, Ades L, et al. Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet. Leukemia. 2015;29:1084–1091.
  • Breccia M, Cicconi L, Minotti C, et al. Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia. Haematologica. 2011;96:1390–1391.
  • Lo Coco F, Cimino G, Breccia M, et al. Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. Blood. 2004;104:1995–1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.